The burden of heart failure is increasing at an alarming rate worldwide. The management of heart failure has evolved over the years with the arrival of new drugs and devices. But the major breakthrough achieved in heart failure medicines is by Angiotensin Receptor–Neprilysin Inhibitor (ARNI). In this exclusive KOL Interview, Dr. Ajit Bhagwat explains how ARNI is beneficial over the conventional treatment for heart failure.
Health Experts: Dr. Ajit Bhagwat is an interventional cardiologist and currently heads the Department of Cardiology at the Kamalnayan Bajaj Hospital in Aurangabad, Maharashtra in India. He was awarded the prestigious Ivan Pinto gold medal from Mumbai university in 1990. He is a member of Cardiological Society of India and Asia Pacific Society of Interventional Cardiology.
